Intra-Cellular Therapies, Inc.

SCHRODER INVESTMENT MANAGEMENT GROUP

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/12/2025

Shares

743,230

Value ($000)

62,045

Weight

0.1%

2019 Q4 - 2024 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/12/2025	62,045	0.1%	743,230	12/31/2024
2024 Q3	11/13/2024	67,742	0.1%	924,171	9/30/2024
2024 Q2	8/12/2024	51,497	0.1%	751,890	6/30/2024
2024 Q1	5/14/2024	42,792	0.1%	618,388	3/31/2024
2023 Q4	2/14/2024	55,851	0.1%	779,823	12/31/2023
2023 Q3	11/14/2023	29,717	0.0%	570,492	9/30/2023
2023 Q2	8/11/2023	45,585	0.1%	719,911	6/30/2023
2023 Q1	5/11/2023	51,225	0.1%	945,985	3/31/2023
2022 Q4	2/10/2023	45,721	0.1%	863,961	12/31/2022
2022 Q3	11/14/2022	40,832	0.1%	877,537	9/30/2022
2022 Q2	8/11/2022	49,010	0.1%	840,516	6/30/2022
2022 Q1	5/16/2022	59,350	0.1%	983,913	3/31/2022
2021 Q4	2/14/2022	61,753	0.1%	1,179,839	12/31/2021
2021 Q3	11/12/2021	42,847	0.1%	1,149,341	9/30/2021
2021 Q2	8/13/2021	53,278	0.1%	1,305,190	6/30/2021
2021 Q1	5/28/2021	44,889	0.1%	1,322,996	3/31/2021
2020 Q4	2/16/2021	41,754	0.1%	1,313,026	12/31/2020
2020 Q3	11/13/2020	23,808	0.0%	999,897	9/30/2020
2020 Q2	8/13/2020	28,739	0.1%	1,119,542	6/30/2020
2020 Q1	5/15/2020	17,304	0.0%	1,117,833	3/31/2020
2019 Q4	2/11/2020	25,832	0.0%	752,895	12/31/2019